Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
weight of evidence
Study period:
08 Mar - 08 Apr 1988
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline with acceptable restrictions. No positive controls were used to show the sensitivity and reliability of the assay.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Remarks:
no positive controls were used to show the sensitivity and reliability of the assay
GLP compliance:
yes
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Reference substance name:
110615-47-9
EC Number:
600-975-8
Cas Number:
110615-47-9
IUPAC Name:
110615-47-9
Details on test material:
- Name of test material (as cited in study report): trade name
- Physical state: yellow viscous liquid
- Analytical purity: no data

In vivo test system

Test animals

Species:
guinea pig
Strain:
Pirbright-Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Interfauna, Tuttlingen, Germany (main study) and Winkelmann, Germany (preliminary study)
- Weight at study initiation: main study: 308.6 (controls) and 310.0 g (test groups); preliminary study: 334.7 g (group A), 312.7 g (group B) and 322.7 g (group C)
- Housing: animals were housed in groups of 5 (preliminary study) or groups of 2-3 (main study) in Makrolon Type IV cages.
- Diet: Altromin-Haltungsdiät 3032 (Altromin GmbH, Lage, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: 6 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 50-60
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
other: undiluted 1,2-propylene glycol (epicutaneous); 20% 1,2-propylene glycol (intradermal)
Concentration / amount:
Induction, intradermal: 0.1%
Induction, epicutaneous: 10%
Challenge: 1.25 and 2.5%
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
other: undiluted 1,2-propylene glycol (epicutaneous); 20% 1,2-propylene glycol (intradermal)
Concentration / amount:
Induction, intradermal: 0.1%
Induction, epicutaneous: 10%
Challenge: 1.25 and 2.5%
No. of animals per dose:
20 (controls), 20 (test groups), 15 (preliminary study)
Details on study design:
RANGE FINDING TESTS:
A. Group A (5 animals) - Intradermal induction
- Test concentrations: 0.1, 0.5, 1.0 and 2.0%
- Results: 0.1% of the test substance was chosen for the main study, since it caused significant skin irritation and no necrosis.

B. Group B (5 animals) - Epicutaneous induction
Test concentrations: 5 and 10%
-Results: 10% of the test substance provoked slight skin irritation and eschar formation and was chosen as concentration for the main assay.

C. Group C (5 animals) - Challenge
Challenge: 2.5 and 5%
- Results: 2.5% of the test substance was selected for the main study, since 5% caused slight irritations in 4/5 animals.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)

- Test groups:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA in 0.9% NaCl solution
Injection 2: test substance in 20% 1,2-propylene glycol
Injection 3: test substance in a 1:1 mixture (v/v) FCA/0.9% NaCl
Epicutaneous: test substance in 1,2-propylene glycol

- Control group:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) FCA in 0.9% NaCl solution
Injection 2: 20% 1,2-propylene glycol
Injection 3: 20% 1,2-propylene glycol in a 1:1 mixture (v/v) FCA/0.9% NaCl
Epicutaneous: 1,2-propylene glycol

- Site: shoulder region (intradermal and epicutaneous)
- Frequency of applications: twice (Day 1 and Day 8)
- Duration: Days 0-8
- Concentrations: intradermal 0.1%, epicutaneous 10%

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day of challenge: 22
- Exposure period: 24 h
- Test groups: test substance in 1,2-propylene glycol
- Control group: test substance in 1,2-propylene glycol
- Site: right flank (test substance)
- Concentrations: 1.25 and 2.5%
- Evaluation (hr after challenge): 24 and 48 h
Challenge controls:
The control group is actually a challenge control.
Positive control substance(s):
no

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
induction: 0%; challenge: 1.25%
No. with + reactions:
1
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: induction: 0%; challenge: 1.25%. No with. + reactions: 1.0. Total no. in groups: 20.0.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
induction: 0%; challenge: 2.5%
No. with + reactions:
3
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: induction: 0%; challenge: 2.5%. No with. + reactions: 3.0. Total no. in groups: 20.0.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
induction: 0.1%; challenge: 1.25%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: induction: 0.1%; challenge: 1.25%. No with. + reactions: 0.0. Total no. in groups: 20.0.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
induction: 0.1%; challenge: 2.5%
No. with + reactions:
1
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: induction: 0.1%; challenge: 2.5%. No with. + reactions: 1.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
induction: 0%; challenge: 1.25%
No. with + reactions:
1
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: induction: 0%; challenge: 1.25%. No with. + reactions: 1.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
induction: 0%; challenge: 2.5%
No. with + reactions:
1
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: induction: 0%; challenge: 2.5%. No with. + reactions: 1.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
induction: 0.1%; challenge: 1.25%
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: induction: 0.1%; challenge: 1.25%. No with. + reactions: 0.0. Total no. in groups: 20.0.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
induction: 0.1%; challenge: 2.5%
No. with + reactions:
1
Total no. in group:
20
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: induction: 0.1%; challenge: 2.5%. No with. + reactions: 1.0. Total no. in groups: 20.0.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
CLP: not classified
DSD: not classified